Hemolymph is the circulating fluid of insects and is a key component of their immune system. However, little is known concerning hemocyte identification, development, differentiation and related cellular immune responses. The present study aimed to determine whether a hemocyte extract prepared from Bombyx mori larvae had anti-inflammatory effects; THP-1 (a human monocytic leukemia cell line) cells that had been differentiated into macrophage-like cells by treatment with phorbol myristate acetate (PMA) were used. THP-1 cells were cultured with different concentrations of a B. mori hemocyte extract prior to exposure to lipopolysaccharide (LPS) to induce an inflammatory response. The effects of the B. mori hemocyte extract on anti-inflammatory pathways were determined using reverse transcription-quantitative polymerase chain reaction and western blotting to assess the expression of pro-inflammatory molecules. The B. mori hemocyte extract inhibited the LPS-induced mRNA expression of Toll-like receptor 4 in addition to LPS-induced interleukin (IL)-1β, IL-6, IL-8 and tumor necrosis factor-α. Treatment of PMA-differentiated THP-1 cells with B. mori hemocyte extract also inhibited inducible nitric oxide synthase and cyclooxygenase-2 transcription and translation. Nuclear factor-κB activation and phosphorylation also decreased. Further in-depth functional studies are required to understand the mechanism underlying the anti-inflammatory effects of silkworm hemocyte extract.
Introduction
The silkworm, Bombyx mori, is considered to have been domesticated from the wild silkworm, Bombyx mandarina, ~5,000-10,000 years ago and is a typical Lepidopteran insect (1, 2) . In the silkworm hemolymph, there are five types of circulating hemocytes; prohemocytes, granulocytes, plasmatocytes, spherulocytes and oenocytoids, all of which are directly or indirectly involved in humoral and cellular immunity (3) . Hemocytes are a key component of insect immunity (3) (4) (5) (6) . Insects possess an innate immune system composed of cellular and humoral mechanisms that respond to invasion by microorganisms (2) . The humoral immune response includes the production of antimicrobial peptides (AMPs) and pro-phenoloxidase (PPO) (3) (4) (5) (6) (7) (8) (9) (10) . AMPs are a particularly important component of insect immunity and are primarily produced by hemocytes and fat bodies to combat invading microorganisms (3, (11) (12) (13) (14) (15) (16) (17) (18) .
The inflammation process is mainly associated with the response of the host organism to exogenous pathogens in addition to the response to bodily injury (19) (20) (21) . Macrophages serve a critical role in the initiation and propagation of inflammatory responses by releasing pro-inflammatory mediators, including nitric oxide (NO), prostaglandin E2 (PGE2) and cytokines that then orchestrate the inflammatory response (22) (23) (24) . Therefore, the amount of pro-inflammatory mediators and cytokines reflects the degree of inflammation and provides information that can help illuminate the effect of pharmacological agents on the inflammatory process (6) . Lipopolysaccharide, (LPS) isolated from gram-negative bacterial cell walls, has been identified to be one of the most potent activators of the immune response and it induces the expression of pro-inflammatory cytokines in animals and humans (25) (26) (27) (28) . Of relevance to the present study, previous studies have demonstrated that LPS can stimulate macrophages, in addition to astrocytes, to increases production of NO, tumor necrosis factor (TNF)-α, cyclooxygenase (COX)-2 and interleukin (IL)-1β (25, 29, 30 (22, 31, 32) . TLR4 is expressed on myeloid-derived cells, including macrophages and dendritic cells, in addition to certain epithelial and endothelial cells, and is an essential component of the innate immune response (33, 34) . The LPS-initiated signaling cascade leads to activation of the mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-κB signaling pathways in a myeloid differentiation factor (MyD) 88-dependent or MyD88-independent manner (22, 35, 36) . Activation of TLR4 involves multiple co-receptors, including lipopolysaccharide-binding protein, myeloid differentiation protein-2 (MD-2) and cluster of differentiation 14. These co-receptors mediate ligation and transfer of LPS to TLR4 (33, 37) . This ligation induces TLR4 dimerization and activates an MyD88-dependent early response signaling pathway that results in the production of pro-inflammatory cytokines including TNF-α, IL-1β and IL-6 (33, 38) . The current study aimed to determine whether a hemocyte extract prepared from B. mori larvae has anti-inflammatory effects. To establish an immune response, human THP-1 cells that had been differentiated into macrophage-like cells by treatment with phorbol myristate acetate (PMA) and which were then stimulated with LPS were used. The inhibitory properties of the hemocyte extract from B. mori on the LPS-stimulated inflammatory response in these THP-1 cells, the cytotoxic effects of the extract on THP-1 cells and the effects of the extract on the LPS-induced production of cytokines, including IL-6 and TNF-α, were investigated.
Materials and methods
Silkworm collection and cell culture. The 3 day (fifth instar) larvae of B. mori (Baekokjam, Jam 123xJam 124) used in the present study were housed at the National Academy of Agricultural Science (Republic of Korea). The silkworms were reared on fresh mulberry leaves at 25˚C, 65-75% relative humidity, using a 12-h light/dark cycle. Fifth-instar larvae were dissected to collect the hemocytes. The samples were immediately frozen and stored in liquid nitrogen. The extracted samples were freeze-dried using an FD-1 freeze dryer (Eyela; Tokyo Rikakikai Co., Ltd., Tokyo, Japan) and stored at 4˚C in a vacuum container until further use. The THP-1 human monocytic leukemia cell line was supplied by the Korean Cell Line Bank (Seoul, Korea). Cells were cultured in RPMI 1640 medium containing 10% fetal bovine serum and antibiotics (all from Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA). For differentiation into macrophages, THP-1 cells were incubated at 37˚C in a humidified 5% CO 2 atmosphere and treated with 100 nM PMA (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) for 72 h. Following differentiation, non-attached cells were removed by aspiration. The adherent macrophages were then washed three times with RPMI 1640 medium and incubated in cell culture medium at 37˚C.
Cell viability assay. Cells were seeded at a density of 1x10 4 cells/well in 96-well plates and incubated with various concentrations (0, 50, 100, 200, 300, 400 and 500 ppm) of freeze-dried hemocyte extract at 37˚C for 24 h. Cell numbers were measured with the Cell Titer 96 Aqueous One solution which contained phenazine ethosulfate (PES) and 3-(4,5-dimet hyl-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl) -2H-tetrazolium, inner salt (MTS; Promega Corporation, Madison, WI, USA). Absorbance was determined at 490 nm, with background subtraction at 650 nm using an Emax microplate reader (Molecular Devices, LLC, Sunnyvale, CA, USA).
Treatment with LPS and freeze-dried hemocytes. THP-1 cells were pre-treated for 2 h in serum-free medium with freeze-dried hemocyte extract and then incubated with LPS (1 µg/ml) for 4 h (for mRNA expression) or 20 h (for protein expression). At each time point, total RNA and protein were isolated from the cultured THP-1 cells.
cDNA synthesis and reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Total RNA was purified from cultured cells using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. For first-strand cDNA synthesis, 1 µg total RNA was transcribed to cDNA using a reverse-transcription system with random hexamers (A3500; Promega Corporation) according to the manufacturer's protocol. RT-qPCR was performed on a StepOnePlus Real-Time PCR system with Power SYBR-Green PCR Master Mix (Applied Biosystems; Thermo Fisher Scientific, Inc.). The PCR was performed with 1 µl cDNA in a 20 µl reaction mixture comprising 10 µl Power SYBR Green PCR Master Mix, 2 µl primers and 7 µl PCR-grade water. The PCR program was as follows: A denaturation step at 95˚C for 10 min, 40 cycles each of 95˚C for 15 sec and 60˚C for 1 min. Quantification of gene expression data was calculated using the 2 −ΔΔCq method the crossing point of the target genes with β-actin was calculated using the formula 2-(target gene-β-actin) and the relative amounts were quantified (39) . The sequences of the gene-specific primers used (Bioneer Corporation, Daejeon, Korea) are listed in Table I .
Western blot analysis. THP-1 cells were collected and washed with cold phosphate-buffered saline (Welgene, Daegu, Korea) and lysed using lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM Na 2 EDTA, 1 mM ethylene glycol tetra-acetic acid, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate and 1 mM Na 3 VO 4 , supplemented with 1 µg/ml leupeptin and 1 mM phenylmethylsulfonyl fluoride; Cell Signaling Technology, Inc., Danvers, MA, USA). The protein concentration was determined using a bicinchoninic acid protein assay (Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. A total of 30 µg protein (per sample) was fractionated by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred by electrophoresis onto nitrocellulose membranes. The membranes were blocked with 5% nonfat dry milk for 1 h at room temperature and subsequently incubated overnight at 4˚C with antibodies against inducible nitric oxide synthase (iNOS; cat. no. AB5382; Chemicon; EMD Millipore, Billerica, MA, USA), COX-2 (cat. no. SC-19999; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), NF-κB p65 (cat. no. 8242; Cell Signaling Technology, Inc.), phosphorylated-NF-κB p65 (cat. no. 3031; Cell Signaling Technology, Inc.) and β-actin (A5441; Sigma-Aldrich; Merck KGaA), diluted 1:1,000 with Tris-buffered saline containing 0.05% Tween 20 (TBST). Following washing with TBST for 1 h, the membranes were incubated for 1 h at room temperature with anti-rabbit (cat. no. 7074; Cell Signaling Technology, Inc.) and anti-mouse (cat. no. 7076; Cell Signaling Technology, Inc.) horseradish peroxidase-conjugated secondary antibodies diluted 1:2,500 in TBST. The membranes were subsequently washed with TBST for 1 h and proteins were detected using an enhanced chemiluminescence kit (Santa Cruz Biotechnology, Inc.). Protein expression was analyzed using a Davinch-Chemi™ Chemiluminescence Imaging System (Chemi Fluoro Imager M8 version, CAS-400 Chemi-DOC Image Analyzer; Davinch-K Co. Ltd., Seoul, Korea). Protein band densities were measured using ImageJ analysis software (ImageJ; version 1.44; National Institutes of Health, Bethesda, MD, USA).
Statistical analysis. Data are expressed as the mean ± standard error. Data were compared by one-way analysis of variance and Tukey's post hoc test. Statistical analyses were performed using the GraphPad Prism 5 software (GraphPad Software Inc., San Diego, USA). P<0.05 was considered to indicate a statistically significant difference.
Results

B. mori hemocyte extract does not affect THP-1 cell proliferation.
Cells were treated with various concentrations (0, 50, 100, 200, 300, 400 and 500 ppm) of B. mori hemocyte extract for 24 h and cell proliferation was examined using a PES/MTS-based solution. As demonstrated in Fig. 1 , the B. mori hemocyte extract did not affect the cell proliferation rate (cell viability).
B. mori hemocyte extract inhibits LPS-induced increase in TLR4 mRNA expression in THP-1 cells.
To investigate the effect of B. mori hemocyte extract on TLR2 and TLR4 expression in THP-1 cells, mRNA expression was measured using RT-qPCR. Following LPS stimulation, TLR4 mRNA expression was greater compared with control THP-1 cells. B. mori hemocyte extract suppressed the LPS-induced increase in the mRNA expression of TLR4 but not of TLR2 (Fig. 2) .
B. mori hemocyte extract inhibits LPS-induced iNOS and COX-2 expression.
To examine the effects of the B. mori hemocyte extract on iNOS and COX-2 mRNA and protein expression levels, THP-1 cells were treated with various concentrations of hemocyte extract and LPS. iNOS and COX-2 mRNA and protein expression were measured using RT-qPCR and western blot analyses, respectively. Treatment with the hemocyte extract significantly suppressed LPS-induced upregulated iNOS mRNA expression at all tested concentrations (P<0.01) and iNOS protein expression at 0, 50, 100, 200 and 500 ppm of hemocyte extract (P<0.05 and P<0.01), compared with the control. In particular, at 500 ppm of B. mori hemocyte extract, COX-2 transcription and translation were significantly lower than the control (P<0.01; Fig. 3 ). 
B. mori hemocyte extract inhibits the LPS-induced increase in cytokine mRNA expression in THP-1 cells.
It was then analyzed whether B. mori hemocyte extract affects inflammatory cytokine mRNA transcription using RT-qPCR. In all cases, cytokine mRNA expression increased in LPS treated cells compared with controls; the hemocyte extract suppressed the LPS-induced increases in IL-1β, IL-6, IL-8 and TNF-α mRNA expression in a dose-dependent manner (Fig. 4) . 
B. mori hemocyte extract inhibits LPS-induced NF-κB p65 nuclear translocation.
To investigate the mechanisms underlying inhibition of NF-κB activity, THP-1 cells were treated with various concentrations (0, 50, 100, 200 and 500 ppm) of the B. mori hemocyte extract. NF-κB p65 protein expression was determined by western blot analysis. It was identified that phosphorylation of NF-κB p65 in THP-1 cells treated with 500 ppm hemocyte extract was significantly lower compared with the control (Fig. 5) .
Discussion
B. mori is susceptible to bacterial infections. Its antibacterial immune proteins have been well characterized (2); several AMPs including cecropin, attacin, lebocin and moricin have been detected in B. mori (11, 40, 41) . AMPs are the best-known immune effectors induced by infection; they are synthesized by hemocytes, fat bodies and other tissues, and are regulated by the Toll and immune deficiency signaling pathways (18, 42, 43) . These peptides exhibit a broad spectrum of antimicrobial activity (2) . A distinctive characteristic of insect antimicrobial peptides is their rapid synthesis in specific tissues and secretion into hemolymph following microbial infection (11, 13) . In particular, hemocytes in insects serve an important role in the insect defense system (2). Hemolymph is the principle circulating fluid in insects, similar to mammalian blood; it moves through the open circulatory system and directly bathes organs and tissues (2) . In the field of entomology, hemocytes are a particularly attractive area for research (3) . Using the silkworm as a model, researchers have extensively studied hemocyte identification, development and differentiation, and associated cellular immune responses (3) .
The present study investigated the inhibition of the inflammatory response using an extract of B. mori hemocytes in human monocytic leukemia cells (THP-1 cells). The B. mori hemocyte extract is expected to contain numerous hemocyte-derived bioactive peptides. Activation of TLR4 by LPS is known to initiate signaling events and induce the secretion of pro-inflammatory cytokines and antimicrobial peptides (34, 44) . These proteins evoke inflammation by activating neutrophils, macrophages and dendritic cells (44) . LPS stimulation has also been shown to induce the production of PGE2, IL-1β, IL-6, TNF-α and other cytokines in the air-pouch inflammation model (44) (45) (46) . The current study identified that the B. mori hemocyte extract significantly inhibited TLR4 gene transcription in THP-1 cells. These results suggest that hemocytes serve a regulatory role in inflammation at the level of TLR4 transcription. To the best of our knowledge, the modulation of LPS-activated TLRs by a hemocyte extract has not been previously reported in THP-1 cells.
The NOS and COX systems are crucial in pathophysiological conditions including inflammation and cancer (47, 48) . In the current study, the effects of the B. mori hemocyte extract on the NO signaling pathway were investigated. The results revealed that B. mori hemocyte extract inhibited iNOS and COX-2 mRNA and protein expression. Orostachys japonicus inhibited LPS-induced proinflammatory cytokine (IL-1β, IL-6, IL-8 and TNF-α) mRNA levels in THP-1 cells (49) . The present study also identified that the B. mori hemocyte extract suppressed the LPS-induced increase in IL-1β, IL-6, IL-8 and TNF-α mRNA expression. Taken together, these findings suggest that the hemocyte extract could suppress iNOS and COX-2 at the gene transcription and translation levels in addition to suppressing the transcription of inflammatory cytokine genes in human monocytic leukemia cells.
The mechanism by which the B. mori hemocyte extract exerts its anti-inflammatory effects remains unclear. NF-κB has been reported to mediate the expression of numerous inflammatory genes, the products of which have been identified to be involved in tumorigenesis (47) including those encoding iNOS, COX-2, IL-1β, IL-6 and TNF-α (50,51). In the current study, the phosphorylation level of p65 a protein in the NF-κB pathway was decreased by the B. mori hemocyte extract. This notable finding suggests that modulation of the expression of the inflammatory genes (COX-2 and iNOS) in THP-1 cells treated with hemocyte extracts was likely to be mediated through NF-κB itself.
In conclusion, the findings of the current study demonstrate that the hemocyte extract inhibited LPS-induced TLR4, cytokine and iNOS expression in human monocytic leukemia cells. Furthermore, the hemocyte extract exerted anti-inflammatory effects on LPS-activated human monocytic leukemia cells by inhibiting NF-κB activation. Further functional studies are required for an in-depth analysis of the anti-inflammatory effects of the B. mori hemocyte extract prepared in the present study.
